Peptides DB
Research-centric peptide and protocol reference hub

DSIP vs NAD+ (Nicotinamide Adenine Dinucleotide)

Updated July 29, 2026 · Reviewed by the PeptidesDB Editorial team

DSIP: Research use — not FDA-approvedNAD+ (Nicotinamide Adenine Dinucleotide): Research use — not FDA-approved

A data-driven comparison of DSIP and NAD+ (Nicotinamide Adenine Dinucleotide) (also searched as NAD+ (Nicotinamide Adenine Dinucleotide) vs DSIP) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.

Verdict

DSIP centers on sleep, while NAD+ (Nicotinamide Adenine Dinucleotide) leans toward metabolic. On indexed research, NAD+ (Nicotinamide Adenine Dinucleotide) is ahead (DSIP: 7 studies, Human evidence; NAD+ (Nicotinamide Adenine Dinucleotide): 22, Human evidence). Choose by goal — and read the primary studies. This is research information, not medical advice.

Key takeaways

  • DSIP is strongest for sleep; NAD+ (Nicotinamide Adenine Dinucleotide) for metabolic.
  • Evidence: DSIP Human evidence (7 studies) vs NAD+ (Nicotinamide Adenine Dinucleotide) Human evidence (22).
  • Both are research-use compounds — not FDA-approved.

Effect profiles, overlaid

DSIP: Healing 1.0, Muscle 0.0, Metabolic 1.0, Neuro 3.0, Sleep 5.0, Immune 2.0, Skin 0.0 — NAD+ (Nicotinamide Adenine Dinucleotide): Healing 4.0, Muscle 2.0, Metabolic 5.0, Neuro 3.0, Sleep 2.0, Immune 4.0, Skin 1.0Healing & recovery — 1.0 / 5 · DSIPMetabolic & appetite — 1.0 / 5 · DSIPNeuro & mood — 3.0 / 5 · DSIPSleep & circadian — 5.0 / 5 · DSIPInflammation & immune — 2.0 / 5 · DSIPHealing & recovery — 4.0 / 5 · NAD+ (Nicotinamide Adenine Dinucleotide)Muscle & body comp — 2.0 / 5 · NAD+ (Nicotinamide Adenine Dinucleotide)Metabolic & appetite — 5.0 / 5 · NAD+ (Nicotinamide Adenine Dinucleotide)Neuro & mood — 3.0 / 5 · NAD+ (Nicotinamide Adenine Dinucleotide)Sleep & circadian — 2.0 / 5 · NAD+ (Nicotinamide Adenine Dinucleotide)Inflammation & immune — 4.0 / 5 · NAD+ (Nicotinamide Adenine Dinucleotide)Skin & aesthetics — 1.0 / 5 · NAD+ (Nicotinamide Adenine Dinucleotide)HealingMuscleMetabolicNeuroSleepImmuneSkin
DSIPNAD+ (Nicotinamide Adenine Dinucleotide)

At a glance

DSIPHuman evidence

Delta Sleep-Inducing Peptide | Sleep & Stress Modulator

Strongest: SleepStudies: 7Level: Emerging

Essential Cellular Coenzyme & Anti-Aging Therapy

Strongest: MetabolicStudies: 22Level: Extensively Studied

DSIP vs NAD+ (Nicotinamide Adenine Dinucleotide): side-by-side

MetricDSIPNAD+ (Nicotinamide Adenine Dinucleotide)
ClassSleepLongevity
Regulatory statusResearch use onlyResearch use only
Evidence gradeHuman evidenceHuman evidence
Studies indexed722
Research levelEmergingExtensively Studied
Strongest effectSleep & circadianMetabolic & appetite
Healing & recovery1.04.0
Muscle & body comp0.02.0
Metabolic & appetite1.05.0
Neuro & mood3.03.0
Sleep & circadian5.02.0
Inflammation & immune2.04.0
Skin & aesthetics0.01.0

▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).

Mechanism & pharmacokinetics

PropertyDSIPNAD+ (Nicotinamide Adenine Dinucleotide)
MechanismCoenzyme in redox reactions
RouteIntravenous infusion

Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.

What is DSIP?

Delta Sleep-Inducing Peptide, primarily discussed for sleep quality, stress modulation, and pain.

Full DSIP profile, mechanism & studies →

What is NAD+ (Nicotinamide Adenine Dinucleotide)?

### Summary NAD+ (Nicotinamide adenine dinucleotide) is a crucial coenzyme involved in various metabolic processes, including energy production and cellular repair mechanisms. Recent research highlights its potential roles in protecting against oxidative stress and enhancing therapeutic efficacy in certain cancer treatments.

Full NAD+ (Nicotinamide Adenine Dinucleotide) profile, mechanism & studies →

Which is better for your goal?

GoalBetter fitWhy
HealingNAD+ (Nicotinamide Adenine Dinucleotide)4.0/5 effect signal
MuscleNAD+ (Nicotinamide Adenine Dinucleotide)2.0/5 effect signal
MetabolicNAD+ (Nicotinamide Adenine Dinucleotide)5.0/5 effect signal
NeuroEvenBoth ~3.0/5
SleepDSIP5.0/5 effect signal
InflammationNAD+ (Nicotinamide Adenine Dinucleotide)4.0/5 effect signal
SkinNAD+ (Nicotinamide Adenine Dinucleotide)1.0/5 effect signal

Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.

Can you stack DSIP and NAD+ (Nicotinamide Adenine Dinucleotide)?

People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.

DSIP vs NAD+ (Nicotinamide Adenine Dinucleotide): side effects

DSIP

No community-reported effects logged yet.

NAD+ (Nicotinamide Adenine Dinucleotide)

No community-reported effects logged yet.

Anonymous community reports (count = number of reports), not clinical incidence rates.

What the research says

DSIP has 7 approved studies indexed (Human evidence), and NAD+ (Nicotinamide Adenine Dinucleotide) has 22 (Human evidence). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.

Frequently asked questions

Is DSIP or NAD+ (Nicotinamide Adenine Dinucleotide) better?

It depends on your goal. DSIP is strongest for sleep; NAD+ (Nicotinamide Adenine Dinucleotide) for metabolic. NAD+ (Nicotinamide Adenine Dinucleotide) has more indexed studies (22). See the goal-by-goal breakdown above.

Is DSIP or NAD+ (Nicotinamide Adenine Dinucleotide) better for weight loss?

NAD+ (Nicotinamide Adenine Dinucleotide) shows the stronger metabolic & appetite profile (5.0/5) in the AI-assigned effect profile — though weight-loss outcomes depend on the individual and the evidence base.

Is DSIP or NAD+ (Nicotinamide Adenine Dinucleotide) better for muscle?

NAD+ (Nicotinamide Adenine Dinucleotide) leads on the muscle & body-composition axis (2.0/5).

Which has more research, DSIP or NAD+ (Nicotinamide Adenine Dinucleotide)?

DSIP has 7 approved studies indexed (Human evidence); NAD+ (Nicotinamide Adenine Dinucleotide) has 22 (Human evidence). Higher counts mean more to read, not proven superiority.

Can you stack DSIP and NAD+ (Nicotinamide Adenine Dinucleotide)?

Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.

What are the side effects of DSIP vs NAD+ (Nicotinamide Adenine Dinucleotide)?

DSIP: no community-reported effects logged yet. NAD+ (Nicotinamide Adenine Dinucleotide): none logged yet. These are anonymous reports, not incidence rates — see each profile.

Is DSIP or NAD+ (Nicotinamide Adenine Dinucleotide) FDA-approved?

DSIP is a research-use compound and is not FDA-approved. NAD+ (Nicotinamide Adenine Dinucleotide) is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.

Is NAD+ (Nicotinamide Adenine Dinucleotide) better than DSIP?

For metabolic, NAD+ (Nicotinamide Adenine Dinucleotide) has the edge; for sleep, DSIP does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.

Comparing related peptides

Regulatory & legal status

DSIP and NAD+ (Nicotinamide Adenine Dinucleotide) are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed July 29, 2026.